DABABNEH, HUSSAM MUSA SALEM
 Distribuzione geografica
Continente #
NA - Nord America 4.571
AS - Asia 3.771
EU - Europa 3.080
AF - Africa 347
Continente sconosciuto - Info sul continente non disponibili 240
SA - Sud America 191
OC - Oceania 11
AN - Antartide 1
Totale 12.212
Nazione #
US - Stati Uniti d'America 4.464
VN - Vietnam 1.190
SG - Singapore 1.027
CN - Cina 850
GB - Regno Unito 825
IT - Italia 511
DE - Germania 415
SE - Svezia 326
FR - Francia 225
HK - Hong Kong 223
RU - Federazione Russa 172
IN - India 170
BR - Brasile 137
TG - Togo 136
IE - Irlanda 133
NL - Olanda 107
ZA - Sudafrica 76
CA - Canada 67
FI - Finlandia 67
UA - Ucraina 62
EE - Estonia 58
CI - Costa d'Avorio 53
JO - Giordania 52
NG - Nigeria 45
BE - Belgio 39
JP - Giappone 38
BD - Bangladesh 35
BG - Bulgaria 28
TH - Thailandia 27
AR - Argentina 23
IR - Iran 23
PH - Filippine 19
CH - Svizzera 18
LT - Lituania 18
PL - Polonia 18
TR - Turchia 18
IQ - Iraq 17
MX - Messico 17
TW - Taiwan 15
EC - Ecuador 12
ES - Italia 12
ID - Indonesia 12
PK - Pakistan 12
AT - Austria 11
AU - Australia 10
RO - Romania 8
SC - Seychelles 8
CZ - Repubblica Ceca 7
ET - Etiopia 7
GR - Grecia 7
UZ - Uzbekistan 7
JM - Giamaica 6
KR - Corea 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
EG - Egitto 5
LB - Libano 5
MY - Malesia 4
UY - Uruguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
GH - Ghana 3
KE - Kenya 3
SN - Senegal 3
AL - Albania 2
BF - Burkina Faso 2
CO - Colombia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KG - Kirghizistan 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
PY - Paraguay 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
GD - Grenada 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LC - Santa Lucia 1
LY - Libia 1
MA - Marocco 1
MN - Mongolia 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
Totale 11.964
Città #
Singapore 707
Southend 705
Ashburn 596
Chandler 486
Fairfield 284
San Jose 247
Hong Kong 206
Santa Clara 197
Dong Ket 180
Ho Chi Minh City 180
Hanoi 179
Wilmington 171
Houston 169
Seattle 162
Princeton 153
Lomé 136
Dublin 132
Ann Arbor 127
Beijing 125
Woodbridge 113
Cambridge 93
Nanjing 85
Council Bluffs 80
Boardman 79
Lauterbourg 72
Westminster 70
Padova 68
New York 67
Los Angeles 60
Abidjan 53
Amman 52
Berlin 52
Medford 51
Helsinki 50
Jinan 50
Shenyang 47
Bremen 46
Bologna 44
Milan 44
Abeokuta 41
London 40
Turin 40
Saint Petersburg 39
Brussels 38
Frankfurt am Main 37
Dearborn 35
Haiphong 34
Munich 33
São Paulo 33
Hebei 32
Dallas 31
Tokyo 31
Buffalo 29
Tianjin 28
Da Nang 27
Redondo Beach 27
Sofia 26
Nanchang 25
Guangzhou 23
Jacksonville 22
Florence 21
Toronto 21
Mountain View 20
Changsha 19
Basingstoke 18
Hangzhou 18
Montreal 18
Falkenstein 17
Phoenix 17
Redwood City 17
San Diego 16
Turku 16
Haikou 15
Pune 14
Düsseldorf 13
Rome 13
Fuzhou 12
Biên Hòa 11
Falls Church 11
Ningbo 11
Ottawa 11
Taiyuan 11
Warsaw 11
Yubileyny 11
Bexley 10
Chicago 10
Hải Dương 10
Jiaxing 10
Mülheim 10
Olalla 10
San Francisco 10
Shanghai 10
Mexico City 9
Nuremberg 9
Stockholm 9
Taizhou 9
Torino 9
Atlanta 8
Kunming 8
Norwalk 8
Totale 7.600
Nome #
Adverse Features and Competing Risk Mortality in Patients With High-Risk Prostate Cancer 290
Sex-related penile fracture with complete urethral rupture: A case report and review of the literature 257
ACCURACY OF PET/CT WITH 11-C-CHOLINE IN THE RESTAGING OF RECURRENT PROSTATE CANCER PATIENTS WITH A SINGLE LESION AT BONE SCINTIGRAPHY 246
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 236
Active surveillance for clinically localized renal tumors: An updated review of current indications and clinical outcomes 218
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 217
MRI DISPLAYS THE PROSTATIC CANCER ANATOMY AND IMPROVES THE BUNDLES MANAGEMENT BEFORE ROBOT ASSISTED RADICAL PROSTATECTOMY 215
Can testis-sparing surgery for small testicular masses be considered a valid alternative to radical orchiectomy? A prospective single-center study 213
The prognostic impact of tumour size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma 212
Holmium laser prostatectomy in a tertiary Italian center: A prospective cost analysis in comparison with bipolar TURP and open prostatectomy 207
The impact of a structured intensive modular training in the learning curve of robot assisted radical prostatectomy. 206
Fibrotic Adhesive Toxic-fat (F.A.T.): the association of fibrotic and adhesive perirenal fat with peri-operative outcomes of robot-assisted par tial nephrectomy (RAPN) 203
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and midterm follow-up 200
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 199
ACCURATEZZA DELLA TC/PETCON 11-C-COLINA NELLA RISTADIAZIONE DEI PAZIENTI CON NEOPLASIA PROSTATICA RECIDIVA CON UNA SINGOLA LESIONE ALLA SCINTIGRAFIA OSSEA 198
INFLUENZA DEL PSA TOTALE, DELLA PSA VELOCITY E DEL PSA DOUBLING TIME SULLA DETECTION RATE DELLA 11C COLINA PET/CT IN PAZIENTE CON RIPRESA BIOCHIMICA DOPO PROSTATECTOMIA RADICALE 196
"In-bore" MRI-guided Prostate Biopsy Using an Endorectal Nonmagnetic Device: A Prospective Study of 70 Consecutive Patients 196
The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates 190
COMPLICANZE E MORTALITÀ PERIOPERATORIE DELLA CISTECTOMIA RADICALE: ANALISI RETROSPETTIVA UTILIZZANDO UNA CLASSIFICAZIONE STANDARDIZZATA 189
DUPLICE ENUCLEORESEZIONE RENALE ROBOTICA CON ACCESSO RETROPERITONEALE IN PAZIENTE CON PREGRESSA CHIRURGIA ADDOMINALE, TROMBOCITOPENIA CRONICA E CIRROSI EPATICA 183
NEFRECTOMIA PARZIALE ROBOTICA CON APPROCCIO RETROPERITONEALE A QUATTRO BRACCIA 181
Detection of nodal micro metastases with serial section, immunohistochemistry and real time-polymerase chain reaction in intermediate and high risk prostate cancer patients submitted to radical prostatectomy with extended pelvic lymph node dissection: A perspective study 180
Detection of nodal micro metastases with serial section, immunohistochemistry and real time-polymerase chain reaction in intermediate and high risk prostate cancer patients submitted to radical prostatectomy with extended pelvic lymph node dissection: A perspective study 179
SOPRAVVIVENZA CANCRO SPECIFICA NEI PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE E MALATTIA AGGRESSIVA ALL’ESAME ISTOLOGICO DEFINITIVO. 175
INFLUENZA DEL PSA TOTALE, DELLA PSA VELOCITY E DEL PSA DOUBLING TIME SULLA DETECTION RATE DELLA 11C-COLINA PET/CT IN PAZIENTE CON RIPRESA BIOCHIMICA DOPO PROSTATECTOMIA RADICALE 172
PREOPERATIVE MULTI PARAMETRIC MAGNETIC RESONANCE IMAGING AND NEUROVASCULAR BUNDLE MANAGEMENT: SURGICAL PLAN CHANGE IN COURSE OF Robot-assISTED RADICAL PROSTATECTOMY 172
Patterns of positive surgical margins after surgery in prostate cancer pa tients and their association with clinical recurrence 172
ElectRomagnetic synchronized real-time system for MRI-TRUS fusion targeted biopsy of prostate (Toshiba Aplio 500Tm) in a heterogeneous pa tients cohort: results and compa rison with systematic biopsy 172
Molecular diagnostic tools for the detection of nodal micrometastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: a prospective study. 171
POSSIAMO INCLUDERE NELLA SORVEGLIANZA ATTIVA PER NEOPLASIA PROSTATICA, PAZIENTI CON CGS 3+4 IN UN UNICO PRELIEVO BIOPTICO? RISULTATI A MEDIO TERMINE DI UN SINGOLO CENTRO DOPO REVISIONE ISTOLOGICA SISTEMATICA DEI PRELIEVI BIOPTICI E DEI REPERTI OPERATORI 170
QUAL È L'IMPATTO DEI MARGINI POSITIVI SULLA RIPRESA BIOCHIMICA NEI PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE PER CARCINOMA PROSTATICO? 169
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 168
Role of testis sparing surgery in the conservative management of small testicular masses: oncological and functional perspectives. 168
RIPARAZIONE DI LESIONE DEL RETTO IN CORSO DI PROSTATECTOMIA RADICALE ROBOTICA UTILIZZANDO UN INNESTO PERITONEALE 166
THE VALUE OF HISTOLOGICAL REVISION OF BIOPSY CORES IN PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: COMPARISON WITH SURGICAL SPECIMENS AFTER RADICAL PROSTATECTOMY AND CLINICAL FOLLOW-UP 166
Preoperative Staging With 11C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer. 165
Small Renal Masses Managed With Active Surveillance: Predictors of Tumor Growth Rate After Long-Term Follow-Up. 165
The role of standard biopsy during an MRI-TRUS fusion targeted biopsy: A two cohort study in previous negative biopsy and active surveillance patients 165
Survival, continence and potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes 164
LYMPH NODE DENSITY IN NODE-POSITIVE PATIENTS TREATED WITH RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 163
The Prognostic Impact of Tumor Size on Cancer-Specific and Overall Survival Among Patients With Pathologic T3a Renal Cell Carcinoma 163
Survival, Continence and Potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes. 163
State of the art of PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancer 161
PREDICTING CANCER- SPECIFIC AND OTHER-CAUSE MORTALITY IN ELDERLY PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER: A COMPETING RISK ANALYSIS 161
The prognostic impact of tumour size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma 160
The value of histological revision of biopsy cores in patients suitable for active surveillance: comparison with surgical specimens after radical prostatectomy and clinical follow-up. 159
IMPATTO ECONOMICO DELLA TERAPIA CHIRURGICA A CIELO APERTO ED ENDOSCOPICA PER L’IPERTROFIA PROSTATICA BENIGNA: ANALISI E CONFRONTO DEI COSTI SOSTENUTI NEL 2015 DA UN CENTRO DI TERZO LIVELLO 159
MAGNETIC RESONANCE/ULTR ASOUND-GUIDED FUSION PROSTATE BIOPSY: CANCER DETECTION RATE WITHIN CONSECUTIVE CORES TAKEN 159
LAPAROSCOPIC AND ROBOTIC URETERAL STENOSIS REPAIR: A MULTI-INSTITUTIONAL EXPERIENCE WITH A LONG-TERM FOLLOW UP 159
RISULTATI MORFOLOGICI E FUNZIONALI DELLE NEOVESCICHE ILEALI ORTOTOPICHE:3 TECNICHE A CONFRONTO 156
LINFADENECTOMIA STANDARD VS ESTESA 155
V24: A new single barbed bidirectional suture (Filbloc, Assut SPA) for posterior muscolofascial reconstruction and knotless urethrovesical anastomosis during RARP 151
ROBOT-ASSISTED PARTIAL URETERECTOMY WITH END-TO-END ANASTOMOSIS FOR IATROGEN STENOSIS OF THE PROXIMAL URETER 149
INFLUENZA DELLA DEPRIVAZIONE ORMONALE SUL RISULTATO DELLA 11CCOLINA-PET/CT IN PAZIENTI CON NEOPLASIA PROSTATICA 148
VALIDATION OF PRIAS ACTIVE SURVEILLANCE CRITERIA IN PATIENTS SUBMITED TO RADICAL PROSTATECTOMY 148
THE PROGNOSTIC IMPACT OF TUMOR SIZE ON CANCER-SPECIFIC AND OVERALL SURVIVAL AMONG PATIENTS WITH PATHOLOGIC T3A RENAL CELL CARCINOMA 148
PROSTATECTOMIA ROBOTICA NERVE-SPARING: RUOLO DELLA RISONANZA MAGNETICA PREOPERATORIA 145
RUOLO DELLA TOMOGRAFIA COMPUTERIZZATA MULTIFASICA (TC) NEL MANAGEMENT CLINICO DELLE PICCOLE MASSE RENALI (SRMS). 143
PREOPERATIVE 11C-CHOLINE PET-CT IN INTERMEDIATE, HIGH RISK AND VERY HIGH RISK PROSTATE CANCER PATIENTS: IS THERE STILL ANY ROOM LEFT FOR IT? 141
SURVIVAL AND FUNCTIONAL OUTCOMES AFTER RADICAL PROSTATECTOMY: BIFECTA ACHIEVEMENT IN PATIENTS AGED ≥ 75 YEARS 138
THE IMPACT OF PELVIC LYMPH-NODE DISSECTION AND OF ITS EXTENT ON BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PATHOLOGICAL N0 OR NX AT INTERMEDIATE AND HIGH RISK OF LYMPH-NODE INVASION 136
INFLUENZA DELLA DEPRIVAZIONE ORMONALE SUL RISULTATO DELLA 11C COLINA PET/CT IN PAZIENTI CON NEOPLASIA PROSTATICA 136
THE IMPACT OF PATHOLOGIC FEATURES ON CANCER SPECIFIC SURVIVAL OF PATIENTS WITH CLINICALLY HIGH-RISK PROSTATE CANCER 136
THE IMPACT OF PELVIC LYMPH-NODE DISSECTION AND OF ITS EXTENT ON BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PATHOLOGICAL N0 OR NX AT INTERMEDIATE AND HIGH RISK OF LYMPH-NODE INVASION 134
CAN TESTIS-SPARING SURGERY BE A VALID ALTERNATIVE TO RADICAL ORCHIECTOMY IN SELECTED CASES? A PROSPECTIVE STUDY 134
QUAL'E' L'IMPATTO DEI MARGINI POSITIVI SULLA RIPRESA BIOCHIMICA NEI PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE PER CARCINOMA 128
RUOLO DELLA LYMPH-NODE DENSITY NELL’OUTCOME ONCOLOGICO DEI PAZIENTI CON METASTASI LINFONODALI DA CARCINOMA prostatico SOTTOPOSTI A PROSTATECTOMIA RADICALE E LINFADENECTOMIA PELVICA 127
Small renal masses initially managed using active surveillance: results from a retrospective study with long-term follow-up. 124
V32: Robot-assisted partial cystectomy for the treatment of urachus acinar adenocarcinoma 117
PATIENTS WITH LYMPH-NODE METASTASIS AFTER RADICAL PROSTATECTOMY AND PELVIC LYMPH-NODE DISSECTION ARE NOT ALL SUBJECT TO THE SAME RISK OF CANCER DEATH: IDENTIFYING DIFFERENT RISKCATEGORY ACCORDING TO THE NUMBER OF POSITIVE NODES AND GLEASON SCORE 106
PRESERVATION OF INTERNAL VESICAL SPHINCTER AND PROXIMAL URETHRA DURINGRADICAL PROSTATECTOMY IMPROVES EARLIERCONTINENCE RECOVERY 101
Feasibility and setting of single docking HUGO RAS robot-assisted nephroureterectomy: first European experience 93
Totale 12.212
Categoria #
all - tutte 29.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.987


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.166 0 45 64 59 137 68 21 83 35 107 302 245
2022/20231.807 194 357 120 221 112 119 46 88 330 63 112 45
2023/2024452 41 64 15 48 48 90 45 34 5 32 11 19
2024/20251.597 61 251 123 121 251 101 86 65 8 158 49 323
2025/20263.574 332 189 284 202 444 197 329 94 910 374 136 83
2026/2027169 56 113 0 0 0 0 0 0 0 0 0 0
Totale 12.212